Answers are grounded in this paper and cite their sources.
Recent exploitations of stimuli-responsive polymers as ophthalmic drug delivery systems for the treatment of eye diseases are summarized and discussed.
No takes yet. Share an insight, caveat, or question.
Dung et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: